Transforming growth factor β1, insulin and prostaglandin E1 enhance prostaglandin F2α mitogenic action in Swiss 3T3 cells via separate events  by de Alzaga, Maria Gomez et al.
FEBS Letters 356 (1994) 21-24 
FEBS 14836 
Transforming growth factor Bl, insulin and prostaglandin E, enhance 
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Abstract Transforming growth factorb (TGFBl) had no mitogenic effect in Swiss 3T3 cells, but could increase prostaglandin F, (PGFZa)-induced 
DNA synthesis. Insulin, but not prostaglandin E, (PGEl), further enhanced PGF2cr action at low TGFpl concentrations. TGFBl also acted 
concertedly with the protein kinase C (PKC) activator I-oleoyl-2-acetylglycerol to induce mitogenesis. Thus, it appears that TGFBl and insulin act 
via separate signals, while TGFBl and PGEl might share a common pathway not involving TGF/?l-mediated prostaglandin synthesis. These results 
suggest hat TGFBl might elicit various signalling mechanisms to enhance PGFZa-triggered events. 
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1. Introdnction 
Mammalian cell division involves coordinated events result- 
ing in the onset of DNA synthesis and mitosis [1,2]. Upon a 
variety of mitogenic stimuli, normal cells generate a complex 
signalling network to ensure the regulation of such phenomena 
[l-3]. Transforming growth factor /I (TGFB), a superfamily of 
closely related 25 kDa polypeptides, can either inhibit or induce 
cell division depending on the particular cell type [4-6]. Most 
TGF/? target cells possess three specific receptor molecules 
[5,7]. Upon TGF/3 binding, these receptors undergo complex 
interactions, resulting in arrest of cell division as well as other 
cellular effects [5,7]. Whether the early TGFjI signals inducing 
cell cycle progression occur via such TGFB receptors is not yet 
understood [5]. 
In confluent resting Swiss 3T3 cells, TGFji is not mitogenic, 
but does enhance bombesin-induced DNA synthesis [8]. In 
these cells, prostaglandin F, (PGF2a) and bombesin trigger 
protein kinase C (PKC) and tyrosine kinase (TK) activation 
[9-l 11. These PGF2cz-dependent kinases can be independently 
activated with no mitogenic response. Nevertheless, such con- 
certed kinase action is likely to be a PGF2a requirement to 
stimulate DNA synthesis [lO,l 11. Both insulin, prostaglandm E, 
(PGEI), and the combination of the two, potentiate PGF2cr- 
mediated growth response [9]. 
Such findings pose two basic questions for the understanding 
of TGFB action. The first deals with whether insulin, PGEl 
and TGFB act via separate processes to enhance PGF2a-in- 
duced DNA synthesis. The second concerns whether TGFB- 
elicited events can interact with some PGF2a-dependent ones 
resulting in mitogenesis. 
Here we show that TGFBl potentiates the PGF2a-mediated 
mitogenic response. Such action reflects an enhancement of the 
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ability of cells to initiate DNA synthesis. At low TGFjIl con- 
centrations, insulin, but not PGEl, increased PGF2a action. In 
contrast, at high TGF/31 concentrations insulin further in- 
creased PGF2u-induced glucose uptake. We also reveal that 
TGF/?l can elicit signals complementary to some PGF2a- 
mediated events involved in the induction of DNA synthesis. 
TGFBl and insulin also exert concerted action, since only in 
combination could they induce mitogenesis. These results sug- 
gest that insulin, TGFBl and PGEl enhance the action of 
PGF2a by triggering different events. 
2. Materials and methods 
2. I. Cell culture and DNA synthesis assay 
Swiss mouse 3T3 cells [12] growth and DNA synthesis autoradio- 
graphic assay were carried out as described before [l]. To avoid the 
effect of albumin as a TGF/?l carrier, TGFBl was dissolved at (10 
&ml) in 1 .O mM CHAPS buffer and then further diluted in serum-free 
culture medium. CHAPS has no effect upon DNA synthesis. 
2.2. Measurement of 2-deoxyglucose uptake 
Cells were plated as for the DNA synthesis assay. Uptake assays were 
performed as previously described 1131. 
2.3. Materials 
Recombinant TGFBl was purchased from R&D Minneapolis. Other 
chemicals were from Sigma Chemical Company. Methyl [%Ijthymidine 
(18 Cilmmol) and 2-[l ,Z3IIldeoxyglucose (30 Ci/mmol) were obtained 
from New England Nuclear and American Radiolabeled Chemicals, 
respectively. 
3. Results 
3.1. TGFBI enhancement of PGlQa-induced DNA synthesis 
The effects of TGF/31 upon PGF2a-mediated mitogenesis in 
confluent, resting Swiss 3T3 cells is shown in Fig. 1. Stimulation 
by 40 and 300 &ml PGF2a induced initiation of DNA synthe- 
sis in 15% and 30% of cells, respectively. The addition of 0.05- 
1.0 @ml TGFj?l enhanced PGF2a action. TGFjIl at a con- 
centration of 0.3 @ml in the presence of 300 @ml PGF2a, 
increased the number of cells in S phase up to 80%. At 40 ng/ml 
PGF2a, 1 .O ng/ml TGFjl was required to attain a similar effect 
(Fig. 1A). TGFBl at 0.8 r&ml also reduced the amount of 
PGF2a required to induce a maximal response (Fig. 1B). 
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Fig. 1. (A) TGFpl dose-response of PGF2a-induced DNA synthesis. Additions were as indicated: (0) TGFBl, (0) PGF2a 40 @ml plus TGFpl 
and (A) PGF2a 300 ng/ml plus TGFBl. (B) The effect of TGFpl on PGF2a dose-dependent response: (0) PGF~cc, (0) PGF2a plus TGFBl (1.0 
@ml). DNA synthesis was determined after 28 h of stimulation as indicated in section 2.1. 
3.2. TGFpl, insulin and PGEI enhance PGRa-induced DNA 
synthesis via difserent events 
TGFJ31 action on PGF2a-induced DNA synthesis, with or 
without insulin or PGE 1, are shown in Fig. 2. Concentrations 
of TGFj?l of 0.05-1.0 ng/ml enhanced the PGF2a response. 
Insulin could further increase this effect only at TGFBl values 
of 0.05-0.2 @ml, but PGEl failed to do so (Fig. 2A,B). In 
contrast, PGE 1, insulin or the addition of both, raised PGF2a 
activity (Fig. 2B, insert). Neither TGFpl, insulin, PGEl, nor 
the combination of TGF/?l with PGEl induced DNA synthe- 
sis. However, TGF/31 plus insulin, or both along with PGEl, 
triggered mitogenesis (Fig. 2B). Indomethacin, an inhibitor of 
prostaglandin synthesis, did not block TGF/31 potentiation of 
the PGF2a mitogenic action (not shown). 
3.3. TGFjII action complements PKC-dependent mitogenic 
events 
1-Oleoyl-2-acetylglycerol (OAG) (100 &ml), a permeable 
diacylglycerol analogue and PKC activator [l 1,14,15], did not 
induce DNA synthesis, but in the presence of TGF/?l could 
trigger such a phenomenon (Table 1). Either insulin, PGEl or 
both together acted in concert with OAG to induce mitogenesis 
[15]; yet insulin, though not PGEl, enhanced the actions of 
TGFj?l and OAG on the stimulation of DNA synthesis 
(Table 1). 
3.4. Insulin and TGFJ31 increase PGFZ’a-induced DOG uptake 
The effects of TGFj?l, insulin and PGF2a on 2-deoxyglucose 
(DOG) uptake induction [13] after 6 h are shown in Table 2. 
Both TGFBl (0.8 &ml) and PGF2a (300 &ml) increased 
glucose uptake fivefold. Such effects could be blocked at least 
partially by cycloheximide, a protein synthesis inhibitor, while 
insulin-induced uptake remained unchanged. Both TGFfil and 
insulin were able to enhance the PGF2a-induced uptake. How- 
ever, the addition of both insulin and PGF2a at these concen- 
trations of TGFB resulted in a further potentiated effect. Both 
actions could be blocked by cycloheximide (Table 2). 
4. Discussion 
Much evidence supports the fact that TGFB can either in- 
hibit or stimulate mammalian cell division [4-6]. TGF/3 and a 
BSC-1 cell inhibitor, both identical molecules, enhance the mi- 
togenic action of bombesin in Swiss 3T3 cells [8]. From the 
similarity between the action of TGFB and insulin, it has been 
inferred that both enhance bombesin-induced mitogenesis via 
a common signalling mechanism [8]. 
Our findings reveal that in these cells, insulin and TGFpl 
elicit separate vents, increasing PGFZa-mediated induction of 
mitogenesis and glucose uptake. Low, but not high, concentra- 
tions of TGFpl allow insulin to further potentiate the PGF2a- 
induced growth response. Such an effect might be reflecting a 
TGFBl-dependent low signal threshold, requiring an insulin- 
triggered signal for full enhancement. In contrast, high concen- 
Table 1 
Complementary mitogenic induction by insulin, PGEl, OAG and/or 
TGFBl 
Additions % labeled nuclei 
- insulin + insulin 
None 0.5 0.1 
OAG 0.5 35.1 
TGF/31 0.8 10.0 
PGEl 0.9 0.7 
OAG+TGFpl 61.0 78.0 
OAG+PGEI 20.0 58.0 
OAG+PGEl+TGFpl 63.0 80.0 
Insulin (50 &ml), OAG (lOO&ml), PGEl (100 &ml) and/or TGFBl 
(0.8 @ml) were added for 28 h. Induction of DNA synthesis was 
determined as in Fig. 1. 
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Fig. 2. Insulin and PGEl action on PGF2cc-mediated mitogenesis at various concentration of TGFBl. Cells were exposed to PGF2a (300 @ml) 
with or without TGFBl, insulin (50 @ml) and/or PGEl (100 ng/ml). In A: (0) PGF2u plus TGFpl, (m) PGF2a plus insulin and TGFBl. In 
B: (0) PGF2a plus TGFpl, (*) PGF2a plus PGEl and TGFpl, (0) TGFpl, (A) TGF/?l plus insulin, (0) TGFjl plus PGEl, (A) TGFjIl plus insulin 
and PGEl. Insert: a, PGF2a; b, PGF2cc plus insulin; c, PGF2a plus PGEl; d, PGF2a plus PGEl and insulin. Cells were labeled as in Fig. 1. 
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trations of TGFBl, might either raise such a threshold or trig- 
ger other signal(s), thereby fully potentiating PGF2a-induced 
mitogenesis. Nevertheless, under the latter conditions, insulin 
can still enhance glucose uptake. 
Further differences between the actions of TGFj?l and insu- 
lin are supported by the fact that neither TGFjIl nor insulin 
are mitogenic by themselves, but together can induce DNA 
synthesis. Moreover, the addition of TGFpl in combination 
with PGEl failed to do so, yet PGEl enhance TGFBl action 
in the presence of insulin. In contrast to insulin, PGEl added 
together with PGF2cc at low TGFjIl concentrations, cannot 
cause further mitogenic enhancement. Such results suggest hat 
TGF/%l and PGEl might be eliciting a common event. TGF/Jl 
action does not involve PGEl synthesis since indomethacin, 
which blocks PGEl formation, did not impair the enhanc- 
ing action of TGFBl [16,17]. Nevertheless, TGFj?l- and 
PGEl-dependent events are not completely identical, since in- 
Table 2 
Effect of TGFBl and insulin upon PGF2a-induced 2-DOG uptake 
Additions 2-DOG uptake 
(pmol/min/mg of protein) 
- cx + cx 
None 100 
TGF/31 3:: 190 
Insulin 210 280 
PGF2a 321 130 
PGFZa+insulin 882 225 
PGF2a+TGF/?l 1852 240 
PGFZa+insulin+TGF/Il 2804 436 
Additions were as follows: insulin (100 ng/ml), PGF2cc (300 q/ml and 
TGFBl (0.8 @ml). Upon 6 h of stimulation cells were labeled for 10 
min with 2.5 &i of 2-[1,2-‘Hldeoxyglucose (50 PM) as indicated in 
section 2.2. 
sulin induces mitogenesis in the presence of TGF/?l but not 
PGEl. 
TGFjIl signalling processes also differ from those elicited by 
PGF2a in Swiss 3T3 cells. PGF2a rapidly triggers increases in 
cellular contents of inositol 1,4,5 triphosphate, DAG, and Ca” 
mobilization, as well as PKC and TK activation [9,11,18]. In 
contrast, TGFBl neither elicits phosphoinositide metabolism 
nor increases Ca2’ fluxes [8]. However, TGF/Il displays con- 
certed action with some PGF2a-dependent events. In effect, 
DAG can cause PKC and TK activation [l 11, but only in 
combination with TGF/Jl is mitogenesis observed. This effect 
of TGF/?l is potentiated by insulin but not by PGEl, though 
both of the latter have mitogenic effects in the presence of DAG 
WI. 
Such actions of TGFjIl and PGF2a on cell division might 
be relevant to two types of proliferative events. Both molecules 
are released by platelets in wound-healing processes, and thus 
possibly, stimulate the fibroblastic multiplication involved in 
tissue repair [19,20]. Some cancerous and transformed cells 
exhibit increased TGF and prostaglandin synthesis and release, 
causing unrestricted ivision [6,21]. To understand how TGFjL 
and PGF2&-triggered signals lead to either one of these growth 
states is our research endeavour. 
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